InsidersTradesSigma
Track the SenzaGen AB share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, SenzaGen AB has logged 2 public disclosures. Market capitalisation: €173.6m. The latest transaction was disclosed on 21 August 2025 (Purchase). Among the most active insiders: Bengt Peter Nählstedt. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€22,060
2 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Fundamental score
Ranked 24,499 of 29,062 companies
27.3
score / 100
Value19
Quality36
FCF yld-7.1%
Earn yld-6.7%
EV/EBITDA·
ROE-13%
Gross mgn65%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 August 2025
Declarations2 total
250,000 shares@ €0.06790.0097% mcap100.0% of flowTeckningsoptionFI:A003R608-1
10,000 shares@ €0.50770.0029% mcap100.0% of flowAktieISIN SE0010219626FI:A003P059-1
2 of 2 declarations
About SenzaGen AB
SenzaGen AB is a company focused on developing safety tests for chemicals and pharmaceuticals. It specializes in innovative solutions to assess the effects of substances on human health.